CompletedPhase 3NCT00003883
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fred Hutchinson Cancer Center
- Principal Investigator
- Kieren A. Marr, MDFred Hutchinson Cancer Center
- Intervention
- fluconazole(drug)
- Enrollment
- 578 enrolled
- Eligibility
- 13 years · All sexes
- Timeline
- 1998 – 2002
Study locations (2)
- Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
- University of Washington Medical Center, Seattle, Washington, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003883 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.